Latest News about MRNA
Recent news which mentions MRNA
Better Coronavirus Stock: Gilead Sciences vs. Moderna
Today 6:11 EDT
From Motley Fool
From Benzinga
Novavax Shares Surge 7% As It Begins Late-Stage COVID-19 Vaccine Trials
September 24, 2020
From Benzinga
Moderna Analyst On 4 Coronavirus Vaccine Program Risks
September 24, 2020
From Benzinga
Current Updates On COVID-19 Vaccine
September 24, 2020
From Benzinga
FDA Vaccine Committee Head Steps Aside Over Conflict Of Interest With Moderna Role
September 24, 2020
From Benzinga
Johnson & Johnson Starts Late-Stage Coronavirus Vaccine Clinical Trial
September 23, 2020
From Motley Fool
Coronavirus update: U.S. death toll tops 201,000, as daily tally more than doubles
September 23, 2020
From MarketWatch
Why Inovio Pharmaceuticals Stock Is Down Today
September 23, 2020
From Motley Fool
Just 4 in 10 Americans now say they would get a first-generation coronavirus vaccine — and most don’t expect to pay out of pocket
September 23, 2020
From MarketWatch
Johnson & Johnson Advances Coronavirus Vaccine Candidate; EUA Likely In Early 2021
September 23, 2020
From Benzinga
Everything you need to know about what it would take for the FDA to approve a COVID-19 vaccine
September 22, 2020
From MarketWatch
Scientists examine how adults and children fight off COVID-19 — and say it may have implications for vaccine research
September 22, 2020
From MarketWatch
Inovio Defies Market-Wide Weakness: What's Behind The Rally?
September 21, 2020
From Benzinga
'Too Early For Victory Laps': Stock Market Update For The Week Ahead
September 20, 2020
From Benzinga
3 Moderna Analyst Takes On The Coronavirus Vaccine Developer's Pipeline
September 18, 2020
Tickers
MRNA
From Benzinga
Dr. Fauci: ‘We may be able to put this coronavirus outbreak behind us’ — but says the American public must play a critical role
September 18, 2020
From MarketWatch
Is AstraZeneca Still A Safe Bet?
September 17, 2020
From Benzinga
7 Reasons Why A Coronavirus Vaccine May Not Work The Way You Hope
September 17, 2020
From Benzinga
Dr. Offit: Prepare to wear masks and socially distance even after getting COVID-19 vaccine
September 17, 2020
From MarketWatch
Coronavirus update: Global cases near 30 million; Trump contradicts CDC head on vaccine timetable and again derides face masks
September 17, 2020
From MarketWatch
COVID-19 Vaccine Developer Moderna In The Spotlight With R&D Day, 2 Collaborations
September 17, 2020
Tickers
MRNA
From Benzinga
A handful of wealthy countries own more than half of the world’s COVID-19 vaccine supply, warns Oxfam
September 17, 2020
From MarketWatch
The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
September 17, 2020
From Benzinga
A Peek Into The Markets: US Stock Futures Tumble Ahead Of Initial Jobless Claims Data
September 17, 2020
From Benzinga
5 Stocks To Watch For September 17, 2020
September 17, 2020
From Benzinga
Sinovac Plans To Expand COVID-19 Vaccine Trials To Children And Adolescents
September 17, 2020
From Benzinga
AstraZeneca Trial Participant Adverse Events Likely Unrelated To COVID-19 Vaccine: Oxford
September 16, 2020
From Benzinga
AstraZeneca Gets India Go-Ahead To Resume COVID-19 Vaccine Trials, US Nod Awaited
September 16, 2020
From Benzinga
What's Significant About Moderna's Expansion Outside North America
September 16, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.